| 產(chǎn)品名稱 | Apolipoprotein AI, Human Plasma | Athens Research & Technology |
| 產(chǎn)品貨號(hào) | 16-16-120101 |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià),電話:010-67529703 |
| 產(chǎn)品規(guī)格 | size |
| 產(chǎn)品品牌 | Athens Research |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
PRODUCT NUMBER:16-16-120101MW: 28,000 Frozen in 10 mM NH4HCO3, pH 7.4 Storage: -70°C or lower
Buy Purified Native Human Apolipoprotein AI (ApoA1), Human Plasma. 75% of Apo A in HDL is Apo AI. Levels of Apo AI are inversely related to the risk of coronary heart disease. Apo AI is also thought to activate LCAT (lecithin cholesterol acyl tranferase). In normal plasma, Apo AI levels range from 90-130 mg per 100 ml. Purity: >=95% by SDS-PAGE Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. Athens Research & Technology products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research use only. Product Citation: Soffientini, Ugo, et al. "Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis." Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1841.10 (2014): 1372-1382.
Soffientini U, Dolan S, Graham A. Winford, Sidney, Moriah Tobin, and Eitan Gross. "Surface-induced assembly of apolipoprotein AI: Implications for symmetry-driven non-cooperative clustering."Journal of Crystal Growth?343, no. 1 (2012): 38-44. Konno, Shunichi, Masami Tanio, Itsuko Ishii, Kazuhiko Machida, Fumiaki Matsumoto, Kaneshige Satoh, Masayuki Aso, and Yasushi Saito. "Ceiling culture-derived proliferative adipocytes are a possible delivery vehicle for enzyme replacement therapy in lecithin: cholesterol acyltransferase deficiency."?Open Gene Therapy Journal?4 (2011): 1-10.
Scharadin TM, et al.
Prathipati P, Zhu J, Dong X. |
| 產(chǎn)品資料 |